Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes

Experimental Neurology

Volumn 233, Issue 1, 2012, Pages 391-399

  Pierozan, Paula ^a   Zamoner, Ariane ^a   Soska, Ângela Krombauer ^a   De Lima, Bárbara Ortiz ^a   Reis, Karina Pires ^a   Zamboni, Fernanda ^a   Wajner, Moacir ^a   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Calcium; Cell signaling; Cyclin dependent kinase 5; Glutamate receptors; Hyperphosphorylation; Intermediate filaments; Quinolinic acid

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN DEPENDENT KINASE 5; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMIC ACID; INTERMEDIATE FILAMENT PROTEIN; METABOTROPIC RECEPTOR 5; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROFILAMENT M PROTEIN; NEUROFILAMENT PROTEIN; PROTEIN KINASE C; QUINOLINIC ACID;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; EXCITOTOXICITY; GLIA CELL; IN VITRO STUDY; INTERMEDIATE FILAMENT; INTRACELLULAR SIGNALING; NERVE CELL LESION; NEUROMODULATION; NEUROPATHOLOGY; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN TARGETING; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; CELL SURVIVAL; CORPUS STRIATUM; CYTOSKELETON; DRUG INTERACTIONS; ENZYME INHIBITORS; NERVE TISSUE PROTEINS; NEURONS; QUINOLINIC ACID; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION;

EID: 84856208813     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2011.11.005     Document Type: Article

References (93)

1. Ackerley S., Thornhill P., Grierson A.J., Brownlees J., Anderton B.H., Leigh P.N., Shaw C.E., Miller C.C. Neurofilament heavy chain side arm phosphorylation regulates axonal transport of neurofilaments. J. Cell Biol. 2003, 161(3):489-495.
2. Adermark L., Clarke R.B., Soderpalm B., Ericson M. Ethanol-induced modulation of synaptic output from the dorsolateral striatum in rat is regulated by cholinergic interneurons. Neurochem. Int. 2010, 58(6):693-699.
3. Albert B., Johnson A., Lewis J., Raff M., Roberts K., Walter P. Molecular Biology of the Cell Published by Garland Science 2008, Taylor and Francis Group, New York USA Fifth Edition.
4. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986, 321(6066):168-171.
5. Behan W.M., McDonald M., Darlington L.G., Stone T.W. Oxidative stress as a mechanism for quinolinic acid-induced hippocampal damage: protection by melatonin and deprenyl. Br. J. Pharmacol. 1999, 128(8):1754-1760.
6. Bennett D.L., Cheek T.R., Berridge M.J., De Smedt H., Parys J.B., Missiaen L., Bootman M.D. Expression and function of ryanodine receptors in nonexcitable cells. J. Biol. Chem. 1996, 271(11):6356-6362.
7. Bonsi P., Platania P., Martella G., Madeo G., Vita D., Tassone A., Bernardi G., Pisani A. Distinct roles of group I mGlu receptors in striatal function. Neuropharmacology 2008, 55(4):392-395.
8. Bu B., Li J., Davies P., Vincent I. Deregulation of cdk5, hyperphosphorylation, and cytoskeletal pathology in the Niemann-Pick type C murine model. J. Neurosci. 2002, 22(15):6515-6525.
9. Chen Y., Guillemin G.J. Kynurenine Pathway Metabolites in Humans: Disease and Healthy States. Int J of Trypt Res 2009, 2(1):1-19.
10. Ching G.Y., Liem R.K. Analysis of the roles of the head domains of type IV rat neuronal intermediate filament proteins in filament assembly using domain-swapped chimeric proteins. J. Cell Sci. 1999, 112(Pt 13):2233-2240.
11. Connick J.H., Stone T.W. Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo. Br. J. Pharmacol. 1988, 93(4):868-876.
12. Cortes H., Paz F., Erlij D., Aceves J., Floran B. GABA(B) receptors modulate depolarization-stimulated [(3)H]glutamate release in slices of the pars reticulata of the rat substantia nigra. Eur. J. Pharmacol. 2010, 649(1-3):161-167.
13. Daile P., Carnegie P.R., Young J.D. Synthetic substrate for cyclic AMP-dependent protein kinase. Nature 1975, 257(5525):416-418.
14. Dashiell S.M., Tanner S.L., Pant H.C., Quarles R.H. Myelin-associated glycoprotein modulates expression and phosphorylation of neuronal cytoskeletal elements and their associated kinases. J. Neurochem. 2002, 81(6):1263-1272.
15. de Carvalho L.P., Bochet P., Rossier J. The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits. Neurochem. Int. 1996, 28(4):445-452.
16. DeFuria J., Shea T.B. Arsenic inhibits neurofilament transport and induces perikaryal accumulation of phosphorylated neurofilaments: roles of JNK and GSK-3beta. Brain Res. 2007, 1181:74-82.
17. Domenici M.R., Pepponi R., Martire A., Tebano M.T., Potenza R.L., Popoli P. Permissive role of adenosine A2A receptors on metabotropic glutamate receptor 5 (mGluR5)-mediated effects in the striatum. J. Neurochem. 2004, 90(5):1276-1279.
18. Eng L.F., Ghirnikar R.S., Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 2000, 25(9-10):1439-1451.
19. Estrada Sanchez A.M., Mejia-Toiber J., Massieu L. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Arch. Med. Res. 2008, 39(3):265-276.
20. Fuchs E., Weber K. Intermediate filaments: structure, dynamics, function, and disease. Annu. Rev. Biochem. 1994, 63:345-382.
21. Fujiyama F., Stephenson F.A., Bolam J.P. Synaptic localization of GABA(A) receptor subunits in the substantia nigra of the rat: effects of quinolinic acid lesions of the striatum. Eur J Neurosci 2002, 15(12):1961-1975.
22. Funchal C., Dall Bello Pessutto F., de Almeida L.M., de Lima Pelaez P., Loureiro S.O., Vivian L., Wajner M., Pessoa-Pureur R. Alpha-keto-beta-methylvaleric acid increases the in vitro phosphorylation of intermediate filaments in cerebral cortex of young rats through the gabaergic system. J. Neurol. Sci. 2004, 217(1):17-24.
23. Funchal C., de Almeida L.M., Oliveira Loureiro S., Vivian L., de Lima Pelaez P., Dall Bello Pessutto F., Rosa A.M., Wajner M., Pessoa Pureur R. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res. Brain Res. Protoc. 2003, 11(2):111-118.
24. 2+ and cAMP. Neurochem. Res. 2005, 30(9):1139-1146.
25. 2+ mediates the effect of alpha-ketoisocaproic acid on the phosphorylating system of cytoskeletal proteins from cerebral cortex of immature rats. J. Neurol. Sci. 2005, 238(1-2):75-82.
26. Geisler N., Vandekerckhove J., Weber K. Location and sequence characterization of the major phosphorylation sites of the high molecular mass neurofilament proteins M and H. FEBS Lett. 1987, 221(2):403-407.
27. Gill S.R., Wong P.C., Monteiro M.J., Cleveland D.W. Assembly properties of dominant and recessive mutations in the small mouse neurofilament (NF-L) subunit. J. Cell Biol. 1990, 111(5 Pt 1):2005-2019.
28. Grant P., Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 2000, 29(11-12):843-872.
29. Heimfarth L., Loureiro S.O., Reis K.P., de Lima B.O., Zamboni F., Lacerda S., Soska A.K., Wild L., da Rocha J.B., Pessoa-Pureur R. Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats. Arch. Toxicol. 2010.
30. Heins S., Wong P.C., Muller S., Goldie K., Cleveland D.W., Aebi U. The rod domain of NF-L determines neurofilament architecture, whereas the end domains specify filament assembly and network formation. J. Cell Biol. 1993, 123(6 Pt 1):1517-1533.
31. Hisanaga S., Gonda Y., Inagaki M., Ikai A., Hirokawa N. Effects of phosphorylation of the neurofilament L protein on filamentous structures. Cell Regul. 1990, 1(2):237-248.
32. Hisanaga S., Saito T. The regulation of cyclin-dependent kinase 5 activity through the metabolism of p35 or p39 Cdk5 activator. Neurosignals 2003, 12(4-5):221-229.
33. Jaffe H., Veeranna Shetty K.T., Pant H.C. Characterization of the phosphorylation sites of human high molecular weight neurofilament protein by electrospray ionization tandem mass spectrometry and database searching. Biochemistry 1998, 37(11):3931-3940.
34. Kalonia H., Kumar P., Kumar A. Comparative neuroprotective profile of statins in quinolinic acid induced neurotoxicity in rats. Behav. Brain Res. 2011, 216(1):220-228.
35. Kalonia H., Kumar P., Kumar A. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease. Pharmacol. Biochem. Behav. 2011, 96(2):115-124.
36. Kanungo J., Zheng Y.L., Amin N.D., Pant H.C. The Notch signaling inhibitor DAPT down-regulates cdk5 activity and modulates the distribution of neuronal cytoskeletal proteins. J. Neurochem. 2008, 106(5):2236-2248.
37. Katayama T., Tanaka H., Yoshida T., Uehara T., Minami M. Neuronal injury induces cytokine-induced neutrophil chemoattractant-1 (CINC-1) production in astrocytes. J. Pharmacol. Sci. 2009, 109(1):88-93.
38. Kemp B.E., Bylund D.B., Huang T.S., Krebs E.G. Substrate specificity of the cyclic AMP-dependent protein kinase. Proc. Natl. Acad. Sci. U. S. A. 1975, 72(9):3448-3452.
39. Kim S., Coulombe P.A. Intermediate filament scaffolds fulfill mechanical, organizational, and signaling functions in the cytoplasm. Genes Dev. 2007, 21(13):1581-1597.
40. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227(5259):680-685.
41. Lariviere R.C., Julien J.P. Functions of intermediate filaments in neuronal development and disease. J. Neurobiol. 2004, 58(1):131-148.
42. Leal R.B., Goncalves C.A., Rodnight R. Calcium-dependent phosphorylation of glial fibrillary acidic protein (GFAP) in the rat hippocampus: a comparison of the kinase/phosphatase balance in immature and mature slices using tryptic phosphopeptide mapping. Brain Res. Dev. Brain Res. 1997, 104(1-2):1-10.
43. Lee V.M., Otvos L., Carden M.J., Hollosi M., Dietzschold B., Lazzarini R.A. Identification of the major multiphosphorylation site in mammalian neurofilaments. Proc. Natl. Acad. Sci. U. S. A. 1988, 85(6):1998-2002.
44. Li B.S., Veeranna Grant P., Pant H.C. Calcium influx and membrane depolarization induce phosphorylation of neurofilament (NF-M) KSP repeats in PC12 cells. Brain Res. Mol. Brain Res. 1999, 70(1):84-91.
45. Li B.S., Veeranna J.G., Grant P., Pant H.C. Activation of mitogen-activated protein kinases (Erk1 and Erk2) cascade results in phosphorylation of NF-M tail domains in transfected NIH 3T3 cells. Eur J Biochem 1999, 262:211-217.
46. Li B.S., Zhang L., Gu J., Amin N.D., Pant H.C. Integrin alpha(1) beta(1)-mediated activation of cyclin-dependent kinase 5 activity is involved in neurite outgrowth and human neurofilament protein H Lys-Ser-Pro tail domain phosphorylation. J. Neurosci. 2000, 20:6055-6062.
47. Li B.S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A.B., Pant H.C. Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 2002, 21(3):324-333.
48. Liu Y., Peterson D.A., Kimura H., Schubert D. Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J. Neurochem. 1997, 69(2):581-593.
49. Loureiro S.O., de Lima Pelaez P., Heimfarth L., Souza D.O., Wajner M., Pessoa-Pureur R. Propionic and methylmalonic acids increase cAMP levels in slices of cerebral cortex of young rats via adrenergic and glutamatergic mechanisms. Biochim. Biophys. Acta 2005, 1740(3):460-466.
50. Loureiro S.O., Heimfarth L., Pelaez Pde L., Lacerda B.A., Vidal L.F., Soska A., Santos N.G., Andrade C., Tagliari B., Scherer E.B., Guma F.T., Wyse A.T., Pessoa-Pureur R. Hyperhomocysteinemia selectively alters expression and stoichiometry of intermediate filament and induces glutamate- and calcium-mediated mechanisms in rat brain during development. Int. J. Dev. Neurosci. 2010, 28(1):21-30.
51. Loureiro S.O., Heimfarth L., Pelaez Pde L., Vanzin C.S., Viana L., Wyse A.T., Pessoa-Pureur R. Homocysteine activates calcium-mediated cell signaling mechanisms targeting the cytoskeleton in rat hippocampus. Int. J. Dev. Neurosci. 2008, 26(5):447-455.
52. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193(1):265-275.
53. Motil J., Chan W.K., Dubey M., Chaudhury P., Pimenta A., Chylinski T.M., Ortiz D.T., Shea T.B. Dynein mediates retrograde neurofilament transport within axons and anterograde delivery of NFs from perikarya into axons: regulation by multiple phosphorylation events. Cell Motil. Cytoskeleton 2006, 63:266-286.
54. Nixon R.A. The regulation of neurofilament protein dynamics by phosphorylation: clues to neurofibrillary pathobiology. Brain Pathol. 1993, 3(1):29-38.
55. Nixon R.A., Sihag R.K. Neurofilament phosphorylation: a new look at regulation and function. Trends Neurosci. 1991, 14(11):501-506.
56. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., Liao J. "Heads and tails" of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 2006, 31(7):383-394.
57. Orlando L.R., Alsdorf S.A., Penney J.B., Young A.B. The role of group I and group II metabotropic glutamate receptors in modulation of striatal NMDA and quinolinic acid toxicity. Exp. Neurol. 2001, 167(1):196-204.
58. Pant A.C., Veeranna Pant H.C., Amin N. Phosphorylation of human high molecular weight neurofilament protein (hNF-H) by neuronal cyclin-dependent kinase 5 (cdk5). Brain Res. 1997, 765(2):259-266.
59. Paramio J.M., Jorcano J.L. Beyond structure: do intermediate filaments modulate cell signalling?. Bioessays 2002, 24(9):836-844.
60. Perez-De La Cruz V., Elinos-Calderon D., Carrillo-Mora P., Silva-Adaya D., Konigsberg M., Moran J., Ali S.F., Chanez-Cardenas M.E., Perez-De La Cruz G., Santamaria A. Time-course correlation of early toxic events in three models of striatal damage: modulation by proteases inhibition. Neurochem. Int. 2010, 56(6-7):834-842.
61. Pierozan P., Zamoner A., Soska A.K., Silvestrin R.B., Loureiro S.O., Heimfarth L., Mello e Souza T., Wajner M., Pessoa-Pureur R. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Exp. Neurol. 2010, 224(1):188-196.
62. Rekik L., Daguin-Nerriere V., Petit J.Y., Brachet P. gamma-Aminobutyric acid type B receptor changes in the rat striatum and substantia nigra following intrastriatal quinolinic acid lesions. J Neurosci Res 2011, 89(4):524-535.
63. Ribeiro F.M., Paquet M., Cregan S.P., Ferguson S.S. Group I metabotropic glutamate receptor signalling and its implication in neurological disease. CNS Neurol. Disord. Drug Targets 2010, 9(5):574-595.
64. Rigon A.P., Cordova F.M., Oliveira C.S., Posser T., Costa A.P., Silva I.G., Santos D.A., Rossi F.M., Rocha J.B., Leal R.B. Neurotoxicity of cadmium on immature hippocampus and a neuroprotective role for p38 MAPK. Neurotoxicology 2008, 29(4):727-734.
65. Rios C., Santamaria A. Quinolinic acid is a potent lipid peroxidant in rat brain homogenates. Neurochem. Res. 1991, 16(10):1139-1143.
66. Sasaki T., Gotow T., Shiozaki M., Sakaue F., Saito T., Julien J.P., Uchiyama Y., Hisanaga S. Aggregate formation and phosphorylation of neurofilament-L Pro22 Charcot-Marie-Tooth disease mutants. Hum. Mol. Genet. 2006, 15(6):943-952.
67. Schwarcz R., Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 2002, 303(1):1-10.
68. Serysheva I.I., Hamilton S.L. Ryanodine binding sites on the sarcoplasmic reticulum Ca2C release channel. Structure and Function of Ryanodine Receptors 1998, 95-104. R. Sitsapesan, A.J. Willaims (Eds.).
69. Seto D., Zheng W.H., McNicoll A., Collier B., Quirion R., Kar S. Insulin-like growth factor-I inhibits endogenous acetylcholine release from the rat hippocampal formation: possible involvement of GABA in mediating the effects. Neuroscience 2002, 115(2):603-612.
70. Sharma P., Veeranna Sharma M., Amin N.D., Sihag R.K., Grant P., Ahn N., Kulkarni A.B., Pant H.C. Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 2002, 277(1):528-534.
71. Shea T.B., Chan W.K. Regulation of neurofilament dynamics by phosphorylation. Eur. J. Neurosci. 2008, 27(8):1893-1901.
72. Shea T.B., Zheng Y.L., Ortiz D., Pant H.C. Cyclin-dependent kinase 5 increases perikaryal neurofilament phosphorylation and inhibits neurofilament axonal transport in response to oxidative stress. J. Neurosci. Res. 2004, 76(6):795-800.
73. Sihag R.K., Inagaki M., Yamaguchi T., Shea T.B., Pant H.C. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res. 2007, 313(10):2098-2109.
74. Sihag R.K., Nixon R.A. In vivo phosphorylation of distinct domains of the 70-kilodalton neurofilament subunit involves different protein kinases. J. Biol. Chem. 1989, 264(1):457-464.
75. Songyang Z., Blechner S., Hoagland N., Hoekstra M.F., Piwnica-Worms H., Cantley L.C. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr. Biol. 1994, 4(11):973-982.
76. Steiner D., Saya D., Schallmach E., Simonds W.F., Vogel Z. Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits. Cell. Signal. 2006, 18(1):62-68.
77. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 1993, 45(3):309-379.
78. Stone T.W., Perkins M.N. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur. J. Pharmacol. 1981, 72(4):411-412.
79. 2+-dependent cell signaling through calmodulin-activated protein phosphatase and protein kinases minireview series. J. Biol. Chem. 2001, 276(4):2311-2312.
80. Sun D., Leung C.L., Liem R.K. Phosphorylation of the high molecular weight neurofilament protein (NF-H) by Cdk5 and p35. J. Biol. Chem. 1996, 271(24):14245-14251.
81. Szydlowska K., Tymianski M. Calcium, ischemia and excitotoxicity. Cell Calcium 2010, 47(2):122-129.
82. Tavares R.G., Tasca C.I., Santos C.E., Alves L.B., Porciuncula L.O., Emanuelli T., Souza D.O. Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes. Neurochem. Int. 2002, 40(7):621-627.
83. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S.T., Takei K., Matsui H. Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 2002, 22(7):2590-2597.
84. 2+ chelators. J. Cereb. Blood Flow Metab. 1994, 14(6):911-923.
85. Ubersax J.A., Ferrell J.E. Mechanisms of specificity in protein phosphorylation. Nat. Rev. Mol. Cell Biol. 2007, 8(7):530-541.
86. Veeranna Amin N.D., Ahn N.G., Jaffe H., Winters C.A., Grant P., Pant H.C. Mitogen-activated protein kinases (Erk1,2) phosphorylate Lys-Ser-Pro (KSP) repeats in neurofilament proteins NF-H and NF-M. J. Neurosci. 1998, 18(11):4008-4021.
87. Wang Q., Walsh D.M., Rowan M.J., Selkoe D.J., Anwyl R. Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 2004, 24(13):3370-3378.
88. Whitaker A.N., McKay D.G. Studies of catecholamine shock. I. Disseminated intravascular coagulation. Am J Pathol 1969, 56(2):153-176.
89. Xu Z.S., Liu W.S., Willard M.B. Identification of six phosphorylation sites in the COOH-terminal tail region of the rat neurofilament protein M. J. Biol. Chem. 1992, 267(7):4467-4471.
90. Yabe J.T., Jung C., Chan W.K., Shea T.B. Phospho-dependent association of neurofilament proteins with kinesin in situ. Cell Motil. Cytoskeleton 2000, 45(4):249-262.
91. Zamoner A., Heimfarth L., Oliveira Loureiro S., Royer C., Mena Barreto Silva F.R., Pessoa-Pureur R. Nongenomic actions of thyroxine modulate intermediate filament phosphorylation in cerebral cortex of rats. Neuroscience 2008, 156(3):640-652.
92. Zamoner A., Heimfarth L., Pessoa-Pureur R. Congenital hypothyroidism is associated with intermediate filament misregulation, glutamate transporters down-regulation and MAPK activation in developing rat brain. Neurotoxicology 2008, 29:1092-1099.
93. Zhou J., Wang H., Feng Y., Chen J. Increased expression of cdk5/p25 in N2a cells leads to hyperphosphorylation and impaired axonal transport of neurofilament proteins. Life Sci. 2010, 86(13-14):532-537.